These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23287048)

  • 21. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
    Longhi MS; Ma Y; Mitry RR; Bogdanos DP; Heneghan M; Cheeseman P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2005 Aug; 25(1):63-71. PubMed ID: 16005184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Altered frequency of CD4+CD25-Foxp3+ T cells in patients with systemic lupus erythematosus].
    Yan B; Liu Y; Xie QB; Liu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):695-8. PubMed ID: 19664391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang F; Zhu L; Liu Y
    Clin Exp Immunol; 2008 Aug; 153(2):182-7. PubMed ID: 18505426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
    Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
    Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
    Longhi MS; Ma Y; Bogdanos DP; Cheeseman P; Mieli-Vergani G; Vergani D
    J Hepatol; 2004 Jul; 41(1):31-7. PubMed ID: 15246204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CD4
    Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
    Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells.
    Mesquita D; de Melo Cruvinel W; Araujo J; Pucci F; Salmazi K; Kallas E; Andrade L
    Scand J Rheumatol; 2011 Jan; 40(1):41-50. PubMed ID: 20936986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
    Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
    J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Imbalance between Foxp3
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the frequencies and functions of CD4
    Zare M; Namavar Jahromi B; Gharesi-Fard B
    J Reprod Immunol; 2019 Jun; 133():43-51. PubMed ID: 31255887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.